echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > [quick news] take a deep breath on March 14, 2019, and you will become better

    [quick news] take a deep breath on March 14, 2019, and you will become better

    • Last Update: 2019-03-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Take a deep breath and you'll be better A study published in nature human behavior recently found that deep breathing before a task makes you more likely to succeed This process seems to prepare for brain activity and help people do better in some tests Sobel and colleagues at the weizman Institute of Science in Israel want to know if breathing can help people better accomplish their tasks To test this, the team connected about 30 participants to a device that measures how their noses inhale and exhale, then showed them a shape or word Participants have to answer whether the shape is actually possible, and whether the word is real or fabricated Participants start each task by pressing the button On average, they pressed the button within one to two seconds of inhaling, although they didn't realize they did The team confirmed this by asking them later When Sobel and his team controlled the start of shape tasks, rather than using buttons, they found that participants scored an average of 73% on inhale and 68% on exhale Https://www.nature.com/articles/s41562-019-0556-z the world's first evidence-based medicine center of traditional Chinese medicine was established in the Chinese Academy of traditional Chinese medicine, which was commissioned by the State Administration of traditional Chinese medicine and prepared by the Chinese Academy of traditional Chinese medicine, and was opened in Beijing on December 12 This is the world's first evidence-based medicine center in the field of traditional Chinese medicine The center will make use of the advantages of experts from the Chinese Academy of traditional Chinese medicine and cooperate with major domestic scientific research institutions to provide basis for the effectiveness and safety of traditional Chinese medicine With the Chinese Academy of traditional Chinese medicine as the core, China evidence-based medicine center of traditional Chinese medicine will work together with Beijing University of traditional Chinese medicine, China evidence-based medicine center of Sichuan University, evidence-based medicine center of Peking University and other advantageous units in the field to carry out research, method consensus, standard formulation, clinical evaluation, evidence sample management, evidence information service, etc of evidence-based medicine of traditional Chinese medicine Http://www.xinhuanet.com/politics/2019-03/12/c_.htm "China core": let independent intellectual property intelligent technology prevent and control chronic diseases with a nail cap size chip, which contains more than 600000 gene probes, and can predict 10 categories and nearly 170 diseases The biochip developer, Cheng Jing, deputy to the National People's Congress, director of the biochip Beijing National Engineering Research Center and academician of the Chinese Academy of engineering, is committed to making "China core" serve the public health At the second session of the 13th National People's Congress held here, Cheng Jing introduced that a considerable part of hearing disabled people are drug-induced deafness, but due to the lack of gene detection means, it is impossible to distinguish high-risk groups After three years of research, Cheng Jing team developed the world's first genetic deafness gene detection chip In recent years, the situation of chronic diseases in China is grim The state has issued policy documents one after another, emphasizing the promotion of scientific and technological achievements transformation and application of appropriate technologies, focusing on breaking through the key technologies of "Internet +" health care, big data and other applications, and supporting the promotion and application of new technologies and products such as gene detection in the field of chronic disease prevention and control Http://www.chinanews.com/gn/2019/03-13/8778978.shtml Unexpectedly, the latest research on haze and the Arctic shows that if the temperature in the Arctic is higher in summer, the haze in the mid latitude area will be heavier in winter This discovery may serve as a haze warning Recently, a research paper published in climate dynamics by Professor Zhao Chuanfeng of Beijing Normal University and others tells us that the Arctic and haze are a pair of "love each other and kill each other" Zhao Chuanfeng led the team to analyze the correlation between the surface temperature in the Arctic (north of 67.5 degrees north latitude) and the aerosol optical depth (AOD) in the middle latitude (30-60 degrees north latitude) between 1979 and 2016 The results show that in addition to the warming trend, there are two periodic changes in the Arctic, which are about 7 years and 12 years, respectively, while the aerosol in the middle latitude also has 7-9 years and 11-13 years periodic changes The two periodicity are basically consistent In addition to the consistency of periodic changes, the study also has an interesting finding: if the Arctic summer (May and June) is relatively high, then the haze in the winter (December to next February) in the mid latitude region will be more serious Https://link.springer.com/article/10.1007% 2fs00382-019-04706-3 breaks through the rare disease and turns the biological medicine from the concept to the commodity Recently, the new generation of drug combination therapy at-gaa for late-onset Pompeii's disease developed by Amicus company in the United States has been officially recognized as breakthrough therapy by the United States Food and Drug Administration (FDA) At-gaa therapy is a combination of atb200 and at2221 At2221 is a product that has already been listed in the United States Atb200 has successfully completed the transformation of research results on the platform of pharmacology and biology, and has carried out small-scale production At present, it has successfully entered the phase III clinical trial According to the person in charge of YaoMing biology, when it can be put into production on a large scale depends on FDA approval However, this time, it was recognized by FDA as a breakthrough therapy, which will speed up the process of approval and industrialization http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2019-03/14/content_417054.htm?div=-1
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.